Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.76	77.39	170.2	62.53	50.19	12.88
Short-Term Investments	144.3	99.11	201.16	284.42	45.93	-
Cash & Short-Term Investments	204.07	176.5	371.36	346.95	96.12	12.88
Cash Growth	-45.33%	-52.47%	7.04%	260.96%	646.43%	320.13%
Accounts Receivable	0.3	0.45	40.05	15.31	-	-
Other Receivables	0	0.1	0.5	0.5	-	-
Receivables	0.3	0.55	40.55	15.81	-	-
Inventory	-	-	38.32	9.77	-	-
Prepaid Expenses	11.78	12.38	14.43	9.61	5.39	0.76
Other Current Assets	-	-	-	-	3.44	-
Total Current Assets	216.14	189.43	464.67	382.13	104.95	13.64
Property, Plant & Equipment	2.07	2.73	6.41	8.14	0.47	0.15
Other Long-Term Assets	1.46	1.47	46.38	1.19	0.19	0.31
Total Assets	219.68	193.63	517.45	391.45	105.61	14.1
Accounts Payable	4.81	2.94	22.06	6.26	4.37	3.61
Accrued Expenses	12.07	23.95	57.72	38.31	13.02	3.71
Current Portion of Leases	1.06	1.52	2.26	2.04	-	-
Total Current Liabilities	17.93	28.41	82.04	46.61	17.4	7.33
Long-Term Debt	-	-	-	-	-	1.43
Long-Term Leases	0.33	0.46	1.98	4.24	-	-
Other Long-Term Liabilities	-	-	-	-	0.04	0.02
Total Liabilities	18.26	28.87	84.02	50.85	17.43	8.77
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	844.01	771.54	738.18	694.91	4.67	1.19
Retained Earnings	-642.6	-606.69	-304.95	-354.22	-155.85	-67.91
Comprehensive Income & Other	-	-0.09	0.2	-0.09	0.01	-
Total Common Equity	201.42	164.77	433.43	340.61	-151.17	-66.73
Shareholders' Equity	201.42	164.77	433.43	340.61	88.18	5.34
Total Liabilities & Equity	219.68	193.63	517.45	391.45	105.61	14.1
Total Debt	1.38	1.98	4.24	6.28	-	1.43
Net Cash (Debt)	202.69	174.52	367.13	340.67	96.12	11.45
Net Cash Growth	-45.16%	-52.46%	7.77%	254.43%	739.31%	-
Net Cash Per Share	2.79	2.56	5.25	5.82	14.59	1.88
Filing Date Shares Outstanding	89.14	88.6	67.78	66.72	57.86	6.43
Total Common Shares Outstanding	89.08	68.63	66.51	66.51	7.02	5.99
Working Capital	198.21	161.03	382.62	335.52	87.56	6.31
Book Value Per Share	2.26	2.40	6.52	5.12	-21.53	-11.13
Tangible Book Value	201.42	164.77	433.43	340.61	-151.17	-66.73
Tangible Book Value Per Share	2.26	2.40	6.52	5.12	-21.53	-11.13
Machinery	-	1.92	3.55	2.17	0.34	0.05
Construction In Progress	-	0.22	0.59	0.8	0.14	0.06
Leasehold Improvements	-	0.18	0.18	0.18	0.05	0.04

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q